» Articles » PMID: 30266805

Angiomotins Stimulate LATS Kinase Autophosphorylation and Act As Scaffolds That Promote Hippo Signaling

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Sep 30
PMID 30266805
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo pathway controls cell proliferation, differentiation, and survival by regulating the Yes-associated protein (YAP) transcriptional coactivator in response to various stimuli, including the mechanical environment. The major YAP regulators are the LATS1/2 kinases, which phosphorylate and inhibit YAP. LATS1/2 are activated by phosphorylation on a hydrophobic motif (HM) outside of the kinase domain by MST1/2 and other kinases. Phosphorylation of the HM motif then triggers autophosphorylation of the kinase in the activation loop to fully activate the kinase, a process facilitated by MOB1. The angiomotin family of proteins (AMOT, AMOTL1, and AMOTL2) bind LATS1/2 and promote its kinase activity and YAP phosphorylation through an unknown mechanism. Here we show that angiomotins increase Hippo signaling through multiple mechanisms. We found that, by binding LATS1/2, SAV1, and YAP, angiomotins function as a scaffold that connects LATS1/2 to both its activator SAV1-MST1 and its target YAP. Deletion of all three angiomotins reduced the association of LATS1 with SAV1-MST1 and decreased MST1/2-mediated LATS1/2-HM phosphorylation. Angiomotin deletion also reduced LATS1/2's ability to associate with and phosphorylate YAP. In addition, we found that angiomotins have an unexpected function along with MOB1 to promote autophosphorylation of LATS1/2 on the activation loop motif independent of HM phosphorylation. These results indicate that angiomotins enhance Hippo signaling by stimulating LATS1/2 autophosphorylation and by connecting LATS1/2 with both its activator SAV1-MST1/2 and its substrate YAP.

Citing Articles

Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications.

Saadh M, Ahmed H, Kareem R, Kumar Bishoyi A, Roopashree R, Shit D Mol Biol Rep. 2025; 52(1):267.

PMID: 40014178 DOI: 10.1007/s11033-025-10372-y.


The Cell Polarity Protein MPP5/PALS1 Controls the Subcellular Localization of the Oncogenes and in Liver Cancer.

Toth M, Wan S, Schmitt J, Birner P, Wei T, von Bubnoff F Int J Mol Sci. 2025; 26(2.

PMID: 39859373 PMC: 11766031. DOI: 10.3390/ijms26020660.


Understanding the cellular dynamics, engineering perspectives and translation prospects in bioprinting epithelial tissues.

Derman I, Moses J, Rivera T, Ozbolat I Bioact Mater. 2024; 43:195-224.

PMID: 39386221 PMC: 11462153. DOI: 10.1016/j.bioactmat.2024.09.025.


The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway.

Zou W, Lei Y, Ding C, Xiao H, Wang S, Liang S Cell Death Dis. 2024; 15(7):466.

PMID: 38956029 PMC: 11220028. DOI: 10.1038/s41419-024-06860-x.


Tudor-SN promotes cardiomyocyte proliferation and neonatal heart regeneration through regulating the phosphorylation of YAP.

Su C, Ma J, Yao X, Hao W, Gan S, Gao Y Cell Commun Signal. 2024; 22(1):345.

PMID: 38943195 PMC: 11212424. DOI: 10.1186/s12964-024-01715-6.


References
1.
Feng X, Degese M, Iglesias-Bartolome R, Vaque J, Molinolo A, Rodrigues M . Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell. 2014; 25(6):831-45. PMC: 4074519. DOI: 10.1016/j.ccr.2014.04.016. View

2.
Zheng Y, Wang W, Liu B, Deng H, Uster E, Pan D . Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade. Dev Cell. 2015; 34(6):642-55. PMC: 4589524. DOI: 10.1016/j.devcel.2015.08.014. View

3.
Couzens A, Knight J, Kean M, Teo G, Weiss A, Dunham W . Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal. 2013; 6(302):rs15. DOI: 10.1126/scisignal.2004712. View

4.
Leung C, Zernicka-Goetz M . Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms. Nat Commun. 2013; 4:2251. PMC: 3741640. DOI: 10.1038/ncomms3251. View

5.
Guo C, Tommasi S, Liu L, Yee J, Dammann R, Pfeifer G . RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol. 2007; 17(8):700-5. DOI: 10.1016/j.cub.2007.02.055. View